Aptamers and use of the aptamers in the diagnosis and treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9790507
SERIAL NO

14889232

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1, a composition comprising an aptamer, and the use of the aptamer in the diagnosis and treatment of cancer, particularly solid tumors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONNREGINA-PACIS-WEG 3 BONN 53113

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mayer, Günter Bonn, DE 15 47
Schöler, Ursula Maria Katia Troisdorf, DE 1 0
Taghdisi, Heidarian Mohammad Seyed Maschhad, IR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 17, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 17, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00